Skip to main content

rachel-king-glycomimetics-image

Rachel King, co-Founder and Chief Executive Officer of GlycoMimetics, Inc., testified today on behalf of the Biotechnology Innovation Organization (BIO) before the Joint Economic Committee. King discussed the need to build on the success of the JOBS Act, FDASIA’s “breakthrough therapies” designation, as well as policies that provide tax relief and strengthen patent protections.

{iframe}https://www.businesswire.com/news/home/20180725005525/en/Biotech-CEO-Testifies-Joint-Economic-Committee-Pro-Growth{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.